Synthetic peptide homologous to the envelope proteins of retroviruses shares a cross-reacting epitope with the CD4 receptor. 1990

J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
Division of Allergy-Immunology-Bone Marrow Transplantation, Children's Hospital of Philadelphia, Pennsylvania.

A synthetic peptide (CKS-17) homologous to a highly conserved region of the retroviral transmembrane protein p15E was tested for its effect on receptor expression on monocytes. The CKS-17 amino acid sequence is present in several retroviruses including human T-cell lymphotropic virus types I and II and human immunodeficiency virus. The CKS-17 peptide has been previously shown to inhibit monocyte superoxide production, natural killer cell activity, polyclonal B-cell activation, and monocyte-mediated killing by inactivation of interleukin-1. In this study, we demonstrated that the anti-CD4 monoclonal antibody OKT4 binds strongly in vitro to CKS-17-treated human blood monocytes, whereas other antibodies tested were not reactive. This observed binding was the result of direct interaction of OKT4 antibody with the CKS-17 peptide. Moreover, a partial homology was found in amino acid sequence analysis of the CD4 epitope and the CKS-17 peptide.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral

Related Publications

J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
January 1985, Transactions of the Association of American Physicians,
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
October 1987, Journal of immunology (Baltimore, Md. : 1950),
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
May 1986, Journal of immunology (Baltimore, Md. : 1950),
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
October 1985, Science (New York, N.Y.),
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
July 1988, Journal of immunology (Baltimore, Md. : 1950),
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
December 1987, European journal of immunology,
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
January 1987, Proceedings of the National Academy of Sciences of the United States of America,
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
February 2020, Viruses,
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
January 2012, PloS one,
J Rothmann, and N F Hassan, and D E Campbell, and N Kamani, and S D Douglas
March 1992, Journal of leukocyte biology,
Copied contents to your clipboard!